Li Li
Founder bei SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Vermögen: 686 Mio $ am 31.03.2024
Profil
Li Li ist ein Geschäftsmann, der die Shenzhen Hepalink Pharmaceutical Group Co., Ltd. gründete und an der Spitze von 5 verschiedenen Unternehmen stand. Gegenwärtig ist er Vorsitzender der Shenzhen Techdow Pharmaceutical Co., Ltd. und Vorsitzender der Shenzhen Hepalink Pharmaceutical Group Co., Ltd. sowie Vorsitzender und Chief Executive Officer der Hepalink USA, Inc. und Vorsitzender der Shenzhen Duopule Industrial Development Co., Ltd. (beides sind Tochtergesellschaften der Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). Er ist auch im Vorstand von Cytovance Biologics, Inc. (ehemaliger Vorsitzender), Shenzhen Leren Technology Co. Ltd. und Urumqi Feilaishi Equity Investment Co. Ltd. Herr Li erwarb einen Bachelor-Abschluss an der Sichuan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2023 | 514 349 899 ( 41,24% ) | 594 Mio $ | 31.03.2024 | |
HIGHTIDE THERAPEUTICS INC
23,61% | 02.02.2024 | 121 515 210 ( 23,61% ) | 92 Mio $ | 31.03.2024 |
Aktive Positionen von Li Li
| Unternehmen | Position | Beginn |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21.04.1998 |
Shenzhen Leren Technology Co. Ltd.
 Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Director/Board Member | - |
| Urumqi Feilaishi Equity Investment Co. Ltd. | Director/Board Member | - |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | Chairman | - |
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Chief Executive Officer | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Chairman | 13.01.2014 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Director/Board Member | - |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Chairman | - |
Ehemalige bekannte Positionen von Li Li
| Unternehmen | Position | Ende |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 02.02.2024 |
Ausbildung von Li Li
| Sichuan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| HIGHTIDE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Technology Services |
| Urumqi Feilaishi Equity Investment Co. Ltd. | |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Health Technology |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
